| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 12/16/2010 | US20100316667 Genetically stable recombinant modified vaccinia ankara (rmva) vaccines and methods of preparation thereof |
| 12/16/2010 | US20100316666 Multivalent Pneumococcal Polysaccharide-Protein Conjugate Composition |
| 12/16/2010 | US20100316665 Papaya mosaic virus-based vaccines against salmonella typhi and other enterobacterial pathogens |
| 12/16/2010 | US20100316663 Subunit Vaccine for Aquaculture |
| 12/16/2010 | US20100316662 Methods and Compositions for Vaccination Comprising Nucleic Acid and/or Polypeptide Sequences of Chlamydia |
| 12/16/2010 | US20100316661 HIV-1 Envelope Glycoprotein Oligomer and Methods of Use |
| 12/16/2010 | US20100316660 Edible product having an immunostimulating effect |
| 12/16/2010 | US20100316659 Immunostimulatory oligoribonucleotides |
| 12/16/2010 | US20100316658 Method for producing an antitumoral vaccine based on surface endothelial cell antigens |
| 12/16/2010 | US20100316657 Synthetic Archaeal Glycolipid Adjuvants |
| 12/16/2010 | US20100316656 Cytotoxic agents comprising new tomaymycin derivatives and their therapeutic use |
| 12/16/2010 | US20100316655 Compounds with mdr1-inverse activity |
| 12/16/2010 | US20100316654 Neutralizing antibodies to influenza viruses |
| 12/16/2010 | US20100316653 Compositions and methods for diagnosis and treatment of orthopoxviruses |
| 12/16/2010 | US20100316652 Vascular endothelial cell growth factor antagonists |
| 12/16/2010 | US20100316651 Cardiovascular related uses of il-1beta antibodies and binding fragments thereof |
| 12/16/2010 | US20100316650 Soluble mic polypeptides as markers for diagnosis, prognosis and treatment of cancer and autoimmune diseases or conditions |
| 12/16/2010 | US20100316649 Small molecule inhibitors of spleen tyrosine kinase (syk) |
| 12/16/2010 | US20100316648 Novel plasminogen receptor, polypeptides and antibodies thereof |
| 12/16/2010 | US20100316647 Compositions of polypeptides specific to pathogenic strains and their use as vaccines and in immunotherapy |
| 12/16/2010 | US20100316646 Compositions and methods for modulating immune responses |
| 12/16/2010 | US20100316645 Bispecific Antigen Binding Proteins |
| 12/16/2010 | US20100316644 Truncated actriib-fc fusion proteins |
| 12/16/2010 | US20100316643 Targeted antimicrobial moieties |
| 12/16/2010 | US20100316642 Complexes of grp94 with human immunoglobulin g |
| 12/16/2010 | US20100316641 Engineered antibody constant domain molecules |
| 12/16/2010 | US20100316640 Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization |
| 12/16/2010 | US20100316639 Biomarkers for igf-1r inhibitor therapy |
| 12/16/2010 | US20100316638 Antibody Formulations and Use Thereof |
| 12/16/2010 | US20100316637 Compositions and Methods for Diagnosing and Treating Cancer |
| 12/16/2010 | US20100316636 Method of Treating Rheumatoid Arthritis with an IL-6R Antibody |
| 12/16/2010 | US20100316635 Kit for diagnosis of breast cancer using herceptin, a composition comprising herceptin and a method for detecting herceptin-sensitive her2 overexpressed cell using the same |
| 12/16/2010 | US20100316634 Recombinant il-5 antagonists useful in treatment of il-5 mediated disorders |
| 12/16/2010 | US20100316633 Inhibition of angiogenesis |
| 12/16/2010 | US20100316632 Means and methods for enhancing differentiation of haematopoietic progenitor cells |
| 12/16/2010 | US20100316631 Water Soluble Curcumin-Based Compounds |
| 12/16/2010 | US20100316630 Anti-idiotype antibodies of the human monoclonal antibody sc-1, and their production and use |
| 12/16/2010 | US20100316629 Use of gene expression profiling to predict survival in cancer patient |
| 12/16/2010 | US20100316628 Agents and methods for treating respiratory disorders |
| 12/16/2010 | US20100316627 Human antibodies to human IL-6 receptor |
| 12/16/2010 | US20100316626 Methods for treatment and diagnosis of psychiatric disorders |
| 12/16/2010 | US20100316608 Method of Determining A Response To Treatment With Immunomodulatory Composition |
| 12/16/2010 | US20100316607 Hepatitis c virus inhibitors |
| 12/16/2010 | US20100316606 Stabilized formulations of peptides and proteins |
| 12/16/2010 | US20100316605 Inhibitors of phosphatidylinositol 3-kinase |
| 12/16/2010 | US20100316603 Combination Immunogene Therapy |
| 12/16/2010 | US20100316602 Compositions and methods for treatment of angiogenesis in pathological lesions |
| 12/16/2010 | US20100316596 Compositions and methods for treatment of diseases and disorders associated with cytokine signaling |
| 12/16/2010 | US20100316593 Pharmaceutical Formulations |
| 12/16/2010 | US20100316574 Oncofetal Antigen/Immature Laminin Receptor Peptides for the Sensitization of Dendritic Cells for Cancer Therapy |
| 12/16/2010 | US20100316572 Use of fsh receptor ligands for diagnosis and therapy of cancer |
| 12/16/2010 | US20100316568 Diagnostic agent and therapeutic agent for pancreatic cancer |
| 12/16/2010 | US20100316564 Immunological targeting of pathological tau proteins |
| 12/16/2010 | US20100316563 Method For The Preparation Of New Oligoclonal Antibodies |
| 12/16/2010 | CA2765112A1 Benzonaphthyridine-containing vaccines |
| 12/16/2010 | CA2765099A1 Immunological targeting of pathological tau proteins |
| 12/16/2010 | CA2765075A1 Egfr and par2 regulation of intestinal permeability |
| 12/16/2010 | CA2764903A1 Different serotypes of vesicular stomatitis virus as expression vectors for immunization regimens |
| 12/16/2010 | CA2764646A1 Therapeutic agent and assay |
| 12/16/2010 | CA2764562A1 Vaccine therapy for choroidal neovascularization |
| 12/16/2010 | CA2764421A1 Adjuvant compositions comprising a non-ionic isotonicity agent |
| 12/16/2010 | CA2764251A1 Novel compositions |
| 12/16/2010 | CA2688766A1 Compositions and methods for treatment of multiple sclerosis |
| 12/15/2010 | EP2261380A2 Method of preventing virus:cell fusion by inhibiting the function of the fusion initiation region in rna viruses having class I membrane fusogenic envelope proteins |
| 12/15/2010 | EP2261378A2 Method of preventing virus:cell fusion by inhibiting the function of the fusion initiation region in rna viruses having class I membrane fusogenic envelope proteins |
| 12/15/2010 | EP2261377A2 Method of preventing virus:cell fusion by inhibiting the function of the fusion initiation region in rna viruses having class I membrane fusogenic envelope proteins |
| 12/15/2010 | EP2261376A2 Method of preventing virus:cell fusion by inhibiting the function of the fusion initiation region in RNA viruses having class I membrane fusogenic envelope proteins |
| 12/15/2010 | EP2261375A2 Method of Preventing Virus:Cell Fusion By Inhibiting the Function of the Fusion Initiation Region in RNA Viruses Having Class I Membrane Fusogenic Envelope Proteins |
| 12/15/2010 | EP2261374A2 Method of preventing virus:cell fusion by inhibiting the function of the fusion initiation region in rna viruses having class i membrane fusogenic envelope proteins |
| 12/15/2010 | EP2261358A2 Novel streptococcus antigen |
| 12/15/2010 | EP2261357A2 Neisseria meningitidis antigens and compositions |
| 12/15/2010 | EP2261356A2 Neisseria meningitidis antigens and compositions |
| 12/15/2010 | EP2261355A2 Neisseria meningitidis antigens and compositions |
| 12/15/2010 | EP2261354A2 Neisseria meningitidis antigens and compositions |
| 12/15/2010 | EP2261353A2 Neisseria meningitidis antigens and compositions |
| 12/15/2010 | EP2261352A2 Neisseria meningitidis antigens and compositions |
| 12/15/2010 | EP2261351A2 Neisseria meningitidis antigens and compositions |
| 12/15/2010 | EP2261350A2 Neisseria meningitidis antigens and compositions |
| 12/15/2010 | EP2261349A2 Neisseria meningitidis antigens and compositions |
| 12/15/2010 | EP2261348A2 Neisseria meningitidis antigens and compositions |
| 12/15/2010 | EP2261347A2 Neisseria meningitidis antigens and compositions |
| 12/15/2010 | EP2261346A2 Neisseria meningitidis antigens and compositions |
| 12/15/2010 | EP2261345A2 Neisseria meningitidis antigens and compositions |
| 12/15/2010 | EP2261344A2 Neisseria meningitidis antigens and compositions |
| 12/15/2010 | EP2261343A2 Neisseria meningitidis antigens and compositions |
| 12/15/2010 | EP2261342A2 Neisseria meningitidis antigens and compositions |
| 12/15/2010 | EP2261341A2 Neisseria meningitidis antigens and compositions |
| 12/15/2010 | EP2261340A2 Neisseria meningitidis antigens and compositions |
| 12/15/2010 | EP2261339A2 Neisseria meningitidis antigens and compositions |
| 12/15/2010 | EP2261338A2 Neisseria meningitidis antigens and compositions |
| 12/15/2010 | EP2261337A1 DNA sequence and recombinant production of group 4 major allergens from cereals |
| 12/15/2010 | EP2261336A1 DNA sequence and recombinant production of group 4 major allergens from cereals |
| 12/15/2010 | EP2261271A1 Separation material |
| 12/15/2010 | EP2261260A2 Methods for inducing autolysis in infectious bacteria |
| 12/15/2010 | EP2261258A1 MCSP-aligned scFv antibody fragments and use of same |
| 12/15/2010 | EP2261256A2 Methods of inhibiting metastasis |
| 12/15/2010 | EP2261254A2 Anti-amyloid antibodies and uses thereof |
| 12/15/2010 | EP2261250A1 Albumin fusion proteins |
| 12/15/2010 | EP2261249A2 KDR peptides and vaccines comprising the same |
| 12/15/2010 | EP2261248A2 KDR peptides and vaccines comprising the same |